NSAIDs and breast cancer: a possible prevention and treatment strategy.

  title={NSAIDs and breast cancer: a possible prevention and treatment strategy.},
  author={Atin Agrawal and Ian S. Fentiman},
  journal={International journal of clinical practice},
  volume={62 3},
CONTEXT Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit cyclooxygenase (COX) and thereby reduce prostaglandin synthesis. Abnormally upregulated COX and prostaglandins are features of breast cancer so NSAIDs might have a role in treatment and prevention of the disease. OBJECTIVE To review the available epidemiological data on the relation between NSAIDs and risk of breast cancer together with interventional studies in established disease. RESULTS Both case-control and cohort studies… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 45 extracted citations

Synthesis of NSAIDs–Se derivatives as potent anticancer agents

Medicinal Chemistry Research • 2018
View 1 Excerpt


Publications referenced by this paper.
Showing 1-10 of 43 references

Phase II trial of neoadjuvant exemestane (EXE) and celecoxib (CELE): effect on biomarkers

CL Shapiro, SP Povoski, R Jiminez
J Clin Oncol • 2007

Cyclo-oxygenase-2 (COX-2) mRNA expression and hormone receptor status in breast cancer.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology • 2006

Similar Papers

Loading similar papers…